These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2420300)

  • 21. [Arrhythmia in acute myocardial infarction with involvement of the right ventricle].
    Córdoba Tejada M; Olivares A; González-Hermosillo JA; Hurtado Buen Abad L; Virgós A; Cárdenas Loaeza M
    Arch Inst Cardiol Mex; 1989; 59(2):113-9. PubMed ID: 2475074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differential indications for anti-arrhythmia therapy].
    Manz M; Wagner WL; Lüderitz B
    Internist (Berl); 1987 Mar; 28(3):182-9. PubMed ID: 2438248
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dynamics of ventricular arrhythmia in the acute period of myocardial infarction].
    Merkulova IN; Blank ML; Sobolev AV; Ruda MIa
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):69-75. PubMed ID: 2447913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiac arrhythmias. Types and drug therapy (author's transl)].
    Lehmann HU
    MMW Munch Med Wochenschr; 1981 Apr; 123(17):680-6. PubMed ID: 6164919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
    Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
    Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken)].
    Friedemann M
    Schweiz Med Wochenschr; 1975 Jul; 105(30):957-61. PubMed ID: 50620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [When should ventricular extrasystole be treated?].
    Kappenberger L
    Schweiz Med Wochenschr; 1987 Feb; 117(7):239-42. PubMed ID: 2436289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of cardiac arrhythmias in aged patients (author's transl)].
    Hochrein H
    Aktuelle Gerontol; 1980 Jan; 10(1):11-6. PubMed ID: 6158269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Helicoid ventricular tachycardia, torsade de pointes, in acute myocardial infarction].
    Vidal J; Hernández Guevara JL; Cárdenas M
    Arch Inst Cardiol Mex; 1983; 53(3):237-45. PubMed ID: 6194766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance.
    Meeus R; Verpooten GA; De Paep R; Paelinck BP; Neels H; Cooreman S; De Doncker M; Jorens PG
    Clin Toxicol (Phila); 2008 Apr; 46(4):303-6. PubMed ID: 18363124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and 4 properties, in patients with recurrent ventricular tachycardia.
    Cocco G; Strozzi C; Pansini R; Rochat N; Bulgarelli R; Padula A; Sfrisi C; Kamal Al Yassini A
    Eur Heart J; 1984 Feb; 5(2):108-14. PubMed ID: 6723683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.
    Harron DW; Brogden RN; Faulds D; Fitton A
    Drugs; 1992 May; 43(5):734-59. PubMed ID: 1379150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Late ventricular tachycardia in myocardial infarct].
    Smeets JP; Deliège M; Demoulin JC; Kulbertus HE
    Rev Med Liege; 1979 Jun; 34(11):496-506. PubMed ID: 92804
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antifibrillation drugs in tachycardial arrythmia].
    Weidner A
    Med Klin; 1969 Jun; 64(23):1075-80. PubMed ID: 4185574
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of tetrodotoxin and ethmozine on arrhythmias of a dog heart isolated in the late stage of experimental myocardial infarct].
    Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG; Dremin SA
    Biull Eksp Biol Med; 1980 Oct; 90(10):446-8. PubMed ID: 6159013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Propafenon, a new anti-arrhythmic drug (author's transl)].
    Aldor E; Heeger H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1318-22. PubMed ID: 60209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.